Rarity PBC is a mission-driven biotechnology company committed to transforming the lives of individuals with rare genetic diseases by developing and delivering life-saving treatments. As a Public Benefit Corporation (PBC), Rarity is uniquely structured to balance purpose and profit, ensuring its operations prioritize social impact alongside financial performance. This dual focus drives the company to advance groundbreaking therapies while addressing the critical need for accessibility, ensuring patients and their families are at the heart of every decision. By combining innovation with an unwavering commitment to equity, Rarity strives to set a new standard in patient-centered healthcare.